Senior Medical Director, Clinical Development - Neuroscience

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling:  ARV-102 for the treatment of patients with neurodegenerative disorders,ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas, and ARV-806, a KRAS G12D PROTAC for the treatment patients with solid tumors with KRAS G12D mutations.  

On August 8^th 2025, the U.S. Food and Drug Administration (FDA)  accepted the New Drug Application (NDA) for vepdegestrant- an investigational, orally bioavailable PROTAC estrogen receptor degrader- for its use as a monotherapy in the treatment of adults with estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2-), ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. In September 2025, Arvinas and Pfizer announced their plan to jointly select a third party for the out-licensing and commercialization of vepdegestrant.

In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical stage PROTAC androgen receptor protein degrader ARV-766 for the treatment of prostate cancer. The transaction closed in May 2024.

#TeamArvinas is made up of passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.

For more information, please visit www.arvinas.com. 

Position Summary

Arvinas is looking for an experienced Senior Medical Director with the passion and creativity to develop great medicines for neuromuscular and neurodegenerative diseases. The ideal candidate is a physician with experience of a global drug development program and global filing experience who is enthusiastic about applying their knowledge to the cause of patients around the globe who have no approved therapies for their disease. The individual will be a self-starter with excellent management and leadership capabilities who is seeking to lead and be part of an innovative team that will drive the drug development processes from start to finish.

Reporting into the Vice President of Clinical Research, the Senior Medical Director will be primarily responsible for the strategy, development and execution of clinical research and development programs, including the leadership of the pivotal trials and filing activities. This position will serve as a key liaison between company and clinical investigators and establish credible relationships with opinion leaders, regulatory officials and other key stakeholders and partners. The successful candidate will be ready for a career defining experience and have the passion to drive a number of therapeutics for serious debilitating diseases to final approval.

This role can be located at our headquarters in New Haven, CT or work with a hybrid or remote work arrangement from a location within the U.S.

Principal Responsibilities

Key responsibilities of this role include, but are not limited to:

• Partner with discovery and biology leadership and provide clinical input and guidance to develop the neuroscience corporate strategy.
• Responsible for trial design of Phase I/II/III research trials targeting neurologic diseases, requiring expertise and stewardship in the areas of CNS/Neurology
• Directly supervise and monitor trial conduct.

• Work closely with all functions of the organization and external partners to manage trial execution and investigators’ engagement.
• Collaborate in developing global regulatory plans and play a key role in regulatory meetings in partnership with regulatory affairs. Identify opportunities for external collaboration.
• Follow important developments and relevant trends in the scientific literature and develop/maintain contacts with external experts to support understanding of the candidate drug effects and to gain strategic insights to the further development of study and overall program.
• Develop effective relationships with external providers.
• Provide clinical assessments of potential in-licensing assets, identifying novel therapeutics opportunities as well as critical study design and execution challenges.
• Review written materials and provide editorial comments for clinical study reports and manuscripts.
• Ensure consistent practices with the highest ethical standards in compliance with internal SOPs, local regulations, and laws.

Additional Responsibilities, including but not limited to:

• Design and develop clinical study protocols and associated clinical study documents and monitor required documentation in compliance with clinical development plans, GCP, and good medical practice.
• Participate in the selection of clinical investigators, providing guidance to investigators on a study.
• Provide medical supervision for contract research organizations and protocol procedures.
• Provide medical and scientific input in review of clinical data, patient medical safety data, and laboratory values; maintaining an ongoing assessment of the safety profile, and efficacy data as appropriate.
• Provide medical surveillance on Serious Adverse Event (SAE) reporting, and follow-ups.
• Direct and oversee the overall strategy for clinical drug product development and collaborating with Regulatory personnel in IND, CTA, and NDA submission activities as well as submission of IND safety reports.
• Lead the clinical aspect of interactions with regulatory agencies worldwide
• Participate in the planning, writing, and review of Clinical Study Reports, regulatory updates, and submissions.
• Assist with due diligence of new scientific developments.
• Analyze and interpret study data for abstracts or publication as required.
• Support corporate partnering efforts and business development activities by providing medical expertise and participating in partnership committees/task groups.
• Collaborate on overall company strategy and in licensing of new programs.
• Work with the financial group as needed to assist with the production of budgets and timelines for the clinical development team.
• Plan and lead clinical focus groups to create clinical trial and protocol designs.
• Ensure that operational activities are conducted in compliance with all pertinent regulatory or statutory requirements and in accordance with the scientific standards, ethical and professional values, management philosophy, and established priorities, policies, and practices of the Company.
• Lead the medical writing for the preparation of summarization of clinical trial data, including the preparation of study reports, integrated summaries, and clinical portions of package inserts and other product labeling.

Qualifications

• A minimum of 5 years (7+ years strongly preferred) of biotech/pharma clinical development  experience  in  neurological disease therapeutic areas.
• Experience across multiple stages of clinical development, from IND to NDA / BLA .
• Global clinical development experience required, and global filing experience strongly preferred.
• Technical (Medical and Scientific) experience evaluating targets/agents for in licensing or internal development.
• Experience supervising physicians and/or scientific staff in a management or team leader capacity highly desirable.
• Excellent interpersonal and public speaking skills are required for this high visibility position.
• Demonstrated ability to work in a matrix environment with cross-functional teams.
• Must be legally authorized to work in the US without the need for employer sponsorship now or at any time in the future.
• The duties of this role are generally conducted in a home office environment. Employees must be able, with or without an accommodation to use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving and non-linear thought, analysis, and dialogue; collaborate with others; maintain general availability during standard business hours.

Education

• M.D. or equivalent degree is required. Formal training in the areas of Neurology is required.

Arvinas is proud to offer a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, and much more. To learn more about Arvinas, please visit www.arvinas.com

Arvinas is an equal opportunity employer. All qualified applicants will be considered for employment without regard to race, color, religion, sex, sexual orientation, gender identify, national origin, disability or protected veteran status.